This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.
Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.
1hvr
From Proteopedia
OCA (Talk | contribs)
(New page: 200px<br /> <applet load="1hvr" size="450" color="white" frame="true" align="right" spinBox="true" caption="1hvr, resolution 1.8Å" /> '''RATIONAL DESIGN OF P...)
Next diff →
Revision as of 12:02, 8 November 2007
|
RATIONAL DESIGN OF POTENT, BIOAVAILABLE, NONPEPTIDE CYCLIC UREAS AS HIV PROTEASE INHIBITORS
Overview
Mechanistic information and structure-based design methods have been used, to design a series of nonpeptide cyclic ureas that are potent inhibitors, of human immunodeficiency virus (HIV) protease and HIV replication. A, fundamental feature of these inhibitors is the cyclic urea carbonyl oxygen, that mimics the hydrogen-bonding features of a key structural water, molecule. The success of the design in both displacing and mimicking the, structural water molecule was confirmed by x-ray crystallographic studies., Highly selective, preorganized inhibitors with relatively low molecular, weight and high oral bioavailability were synthesized.
About this Structure
1HVR is a Single protein structure of sequence from Human immunodeficiency virus 1 with HYD and XK2 as ligands. Full crystallographic information is available from OCA.
Reference
Rational design of potent, bioavailable, nonpeptide cyclic ureas as HIV protease inhibitors., Lam PY, Jadhav PK, Eyermann CJ, Hodge CN, Ru Y, Bacheler LT, Meek JL, Otto MJ, Rayner MM, Wong YN, et al., Science. 1994 Jan 21;263(5145):380-4. PMID:8278812
Page seeded by OCA on Thu Nov 8 14:08:19 2007
